e-Casos clínicos
Respuesta a omalizumab en 3 casos de urticaria solar
Response to Omalizumab in Solar Urticaria: Report of 3 Cases
P. Rodríguez-Jiménez
, P. Chicharro, A. Pérez-Plaza, D. de Argila
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España
Leído
6828
Vecesse ha leído el artículo
2296
Total PDF
4532
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 56 | 15 | 71 |
| 2025 5 | 82 | 26 | 108 |
| 2025 4 | 89 | 23 | 112 |
| 2025 3 | 84 | 15 | 99 |
| 2025 2 | 91 | 27 | 118 |
| 2025 1 | 59 | 23 | 82 |
| 2024 12 | 48 | 31 | 79 |
| 2024 11 | 69 | 56 | 125 |
| 2024 10 | 55 | 37 | 92 |
| 2024 9 | 50 | 28 | 78 |
| 2024 8 | 88 | 51 | 139 |
| 2024 7 | 108 | 33 | 141 |
| 2024 6 | 102 | 28 | 130 |
| 2024 5 | 110 | 28 | 138 |
| 2024 4 | 77 | 38 | 115 |
| 2024 3 | 64 | 32 | 96 |
| 2024 2 | 59 | 24 | 83 |
| 2024 1 | 68 | 29 | 97 |
| 2023 12 | 46 | 25 | 71 |
| 2023 11 | 46 | 33 | 79 |
| 2023 10 | 44 | 23 | 67 |
| 2023 9 | 47 | 31 | 78 |
| 2023 8 | 60 | 13 | 73 |
| 2023 7 | 93 | 56 | 149 |
| 2023 6 | 44 | 25 | 69 |
| 2023 5 | 60 | 22 | 82 |
| 2023 4 | 45 | 19 | 64 |
| 2023 3 | 43 | 20 | 63 |
| 2023 2 | 69 | 21 | 90 |
| 2022 1 | 49 | 23 | 72 |
| 2022 12 | 45 | 42 | 87 |
| 2022 11 | 76 | 42 | 118 |
| 2022 10 | 71 | 40 | 111 |
| 2022 9 | 91 | 52 | 143 |
| 2022 8 | 71 | 56 | 127 |
| 2022 7 | 70 | 63 | 133 |
| 2022 6 | 78 | 42 | 120 |
| 2022 5 | 78 | 44 | 122 |
| 2022 4 | 127 | 38 | 165 |
| 2022 3 | 120 | 58 | 178 |
| 2022 2 | 172 | 30 | 202 |
| 2021 1 | 138 | 51 | 189 |
| 2021 12 | 80 | 40 | 120 |
| 2021 11 | 88 | 54 | 142 |
| 2021 10 | 61 | 44 | 105 |
| 2021 9 | 45 | 44 | 89 |
| 2021 8 | 54 | 40 | 94 |
| 2021 7 | 46 | 30 | 76 |
| 2021 6 | 51 | 49 | 100 |
| 2021 5 | 46 | 50 | 96 |
| 2021 4 | 104 | 84 | 188 |
| 2021 3 | 86 | 39 | 125 |
| 2021 2 | 81 | 46 | 127 |
| 2020 1 | 58 | 27 | 85 |
| 2020 12 | 48 | 28 | 76 |
| 2020 11 | 47 | 17 | 64 |
| 2020 10 | 49 | 21 | 70 |
| 2020 9 | 60 | 24 | 84 |
| 2020 8 | 49 | 35 | 84 |
| 2020 7 | 35 | 23 | 58 |
| 2020 6 | 48 | 31 | 79 |
| 2020 5 | 38 | 39 | 77 |
| 2020 4 | 37 | 31 | 68 |
| 2020 3 | 42 | 21 | 63 |
| 2020 2 | 10 | 0 | 10 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 9 | 0 | 9 |
| 2019 11 | 3 | 0 | 3 |
| 2019 9 | 10 | 0 | 10 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 6 | 4 | 10 |
| 2019 6 | 6 | 2 | 8 |
| 2019 5 | 6 | 1 | 7 |
| 2019 4 | 2 | 1 | 3 |
| 2019 3 | 2 | 6 | 8 |
| 2019 2 | 5 | 2 | 7 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 8 | 6 | 14 |
| 2018 10 | 6 | 4 | 10 |
| 2018 9 | 6 | 0 | 6 |
| 2018 8 | 1 | 0 | 1 |
| 2018 6 | 2 | 0 | 2 |
| 2018 3 | 2 | 0 | 2 |
| 2018 2 | 3 | 0 | 3 |
| 2018 1 | 8 | 3 | 11 |
| 2017 12 | 8 | 5 | 13 |
| 2017 11 | 5 | 8 | 13 |
| 2017 10 | 16 | 13 | 29 |
| 2017 9 | 0 | 1 | 1 |
| 2017 8 | 0 | 2 | 2 |
| 2017 7 | 0 | 3 | 3 |
| 2017 6 | 0 | 2 | 2 |
| 2017 5 | 0 | 2 | 2 |
| 2017 4 | 0 | 1 | 1 |
Mostrar todo
